TWP Logo Healthcare
Experts in Growth
Deep domain expertise, powerful distribution and long-term relationships that produce results.
RESEARCH

Donald Ellis, PharmD

Managing Director
Pharmaceuticals: Specialty
+1 415.364.7038
dellis@tweisel.com


Donald Ellis covers Specialty Pharmaceuticals at Thomas Weisel Partners. Previously, he was a Managing Director and Senior Pharmaceutical Analyst at Robertson Stephens. Before that, he followed the Emerging and Drug Delivery Pharmaceuticals industry at Montgomery Securities. In 1998, 2001 and in 2006, The Wall Street Journal named him a “Best on the Street Analyst” for his coverage of the Drug Delivery and Specialty Pharmaceuticals sector. Before entering the securities business, he spent ten years in clinical practice at Kaiser Permanente and at the Veterans Administration Hospital in San Diego, California. Donald received a Master of Business Administration degree from the University of San Diego and a Doctorate degree in Pharmacy from the University of Southern California.
Coverage List

Ticker
  Company Name   Rating  
Market Cap (mn)
ALKS
  Alkermes, Inc.   Market Weight  
$1,362 USD
AGN
  Allergan, Inc.   Market Weight  
$17,188 USD
AUXL
  Auxilium Pharmaceuticals, Inc.   Overweight  
$1,651 USD
CEPH
  Cephalon, Inc.   Overweight  
$5,290 USD
CORT
  Corcept Therapeutics Incorporated   Overweight  
$96 USD
EURX
  Eurand N.V.   Overweight  
$765 USD
FRX
  Forest Laboratories, Inc.   Market Weight  
$11,682 USD
ISTA
  ISTA Pharmaceuticals, Inc.   Overweight  
$63 USD
KG
  King Pharmaceuticals, Inc.   Market Weight  
$2,778 USD
MRX
  Medicis Pharmaceutical Corporation   Overweight  
$1,122 USD
OMPI
  Obagi Medical Products, Inc.   Overweight  
$215 USD
SLXP
  Salix Pharmaceuticals, Ltd.   Market Weight  
$351 USD
SNTS
  Santarus, Inc.   Overweight  
$127 USD
SCRX
  Sciele Pharma, Inc.   Overweight  
$611 USD
SOMX
  Somaxon Pharmaceuticals, Inc.   Overweight  
$75 USD
ELOS
  Syneron Medical Ltd.   Market Weight  
$436 USD
THRM
  Thermage, Inc.   Overweight  
$75 USD